56 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
into a mutual target termination agreement, Roche will have rights in and responsibility for any know- how and intellectual property generated … as a result of the collaboration that fits within the Roche Field, and we will have rights in and responsibility for any know-how and intellectual property
8-K
EX-99.1
6bkxzvqmoq4ac
5 Sep 23
C4 Therapeutics Announces Chief Financial Officer Succession
4:02pm
8-K
EX-10.1
6p0d9ysw1
30 May 23
Entry into a Material Definitive Agreement
7:30am
ARS
j04z67sc
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
hlqpao mf
18 Apr 23
Preliminary proxy
7:59am
8-K
EX-99.1
cnb5972pcgitpqb
2 Aug 22
C4 Therapeutics Appoints Experienced Clinical Development Leaders Laura Bessen, M.D. and Donna Grogan, M.D. to Board of Directors
8:33am